Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Cancer Causes & Control
Literature
1.
Checkoway H, Boffetta P, Mundt DJ, Mundt KA (2012) Critical review and synthesis of the epidemiologic evidence on formaldehyde exposure and risk of leukemia and other lymphohematopoietic malignancies. Cancer Causes Control. doi:10.​1007/​s10552-012-0055-2
2.
Zhang L, Tang X, Rothman N, Vermeulen R, Ji Z, Shen M, Qiu C, Guo W, Liu S, Reiss B et al (2010) Occupational exposure to formaldehyde, hematotoxicity, and leukemia-specific chromosome changes in cultured myeloid progenitor cells. Cancer Epidemiol Biomark Prev 19(1):80–88CrossRef
3.
Speit G, Gelbke H-P, Pallapies D, Morfeld P (2010) Letter to the editor: occupational exposure to formaldehyde, hematotoxicity and leukemia-specific chromosome changes in cultured myeloid progenitor cells. Cancer Epidemiol Biomark Prev 19:1882–1884, (author response 1884–1885)
4.
5.
Schwilk E, Zhang L, Smith MT, Smith AH, Steinmaus C (2010) Formaldehyde and leukemia: an updated meta-analysis and evaluation of bias. J Occup Environ Med 52(9):878–886PubMedCrossRef
6.
Zhang L, Steinmaus C, Eastmond DA, Xin XK, Smith MT (2009) Formaldehyde exposure and leukemia: a new meta-analysis and potential mechanisms. Mutat Res 681(2–3):150–168PubMed
7.
Bachand AM, Mundt KA, Mundt DJ, Montgomery RR (2010) Epidemiological studies of formaldehyde exposure and risk of leukemia and nasopharyngeal cancer: a meta-analysis. Crit Rev Toxicol 40(2):85–100PubMedCrossRef
8.
Greenland S, Longnecker MP (1992) Methods for trend estimation from summarized dose-response data, with applications to meta-analysis. Am J Epidemiol 135(11):1301–1309PubMed
9.
Orsini N, Li R, Wolk A, Khudyakov P, Spiegelman D (2012) Meta-analysis for linear and nonlinear dose-response relations: examples, an evaluation of approximations, and software. Am J Epidemiol 175(1):66–73PubMedCrossRef
10.
Royston P, Altman DG, Sauerbrei W (2006) Dichotomizing continuous predictors in multiple regression: a bad idea. Stat Med 25(1):127–141PubMedCrossRef
11.
Rothman KJ, Greenland S, Lash TL (2008) Modern epidemiology, 3rd edn. Lippincott Williams & Wilkins, Philadelphia
12.
Al Khalaf MM, Thalib L, Doi SAR (2011) Combining heterogenous studies using the random-effects model is a mistake and leads to inconclusive meta-analyses. J Clin Epidemiol 64(2):119–123
13.
Riley RD, Higgins JPT, Deeks JJ (2011) Interpretation of random effects meta-analyses. BMJ 342:964–967CrossRef
14.
Graham PL, Moran JL (2012) Robust meta-analytic conclusions mandate the provision of prediction intervals in meta-analysis summaries. J Clin Epidemiol 65(5):503–510PubMedCrossRef
15.
Bolt HM, Morfeld P (2012) New results on formaldehyde: the 2nd international formaldehyde science conference (Madrid, 19–20 April 2012). Arch Toxicol. doi:10.​1007/​s00204-012-0966-4
Metadata
Title
Formaldehyde and leukemia: missing evidence!
Author
Peter Morfeld
Publication date
01-01-2013
Publisher
Springer Netherlands
Published in
Cancer Causes & Control / Issue 1/2013
Print ISSN: 0957-5243
Electronic ISSN: 1573-7225
DOI
https://doi.org/10.1007/s10552-012-0111-y

Other articles of this Issue 1/2013

Cancer Causes & Control 1/2013 Go to the issue

Original paper

The association between cancer and amyotrophic lateral sclerosis

Original paper

CYP2C9 variants increase risk of colorectal adenoma recurrence and modify associations with smoking but not aspirin treatment

Original paper

Insulin-like growth factors (IGFs) and IGF-binding proteins in active monitoring of localized prostate cancer: a population-based observational study

Original paper

Prospective study of effect modification by Toll-like receptor 4 variation on the association between Trichomonas vaginalis serostatus and prostate cancer

Original paper

Red and processed meat intake and risk of esophageal adenocarcinoma: a meta-analysis of observational studies

Original paper

Nutrition in early life and risk of childhood leukemia: a case–control study in Greece
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits